经皮经肝乳头球囊扩张术与内镜逆行胰胆管造影术治疗胆总管结石的多中心前瞻性研究
该多中心前瞻性队列研究纳入531例胆总管结石患者,比较经皮经肝乳头球囊扩张术(PTPBD,360例)与内镜逆行胰胆管造影术(ERCP,171例)的技术成功率与并发症。PTPBD组技术成功率99%(355/360)与ERCP组98%(167/171)相近(相对危险度1.02,P=0.12),但总体并发症发生率PTPBD组4%(13/360)低于ERCP组8%(13/171)(相对危险度0.27,95%CI:0.12,0.61,P<0.001)。PTPBD组透视时间更长、辐射剂量更高,调整后差异分别为28.7分钟(95%CI:22.2,35.2)和384.3 mGy(95%CI:296.5,472)。
要点
- PTPBD与ERCP治疗胆总管结石的技术成功率相近(99% vs 98%,RR 1.02,P=0.12)。
- PTPBD总体并发症发生率低于ERCP(4% vs 8%,RR 0.27,95%CI:0.12,0.61,P<0.001)。
- PTPBD透视时间较ERCP延长28.7分钟,辐射剂量增加384.3 mGy(调整后差异)。
核心结论
- 与ERCP相比,PTPBD技术成功率相似且围手术期并发症更少,但辐射暴露更高。
研究设计与样本
- 多中心前瞻性队列研究,纳入531例有1至3枚胆总管结石(最大结石≤30 mm)且无肝内胆管或胆囊结石的参与者,PTPBD组360例(中位年龄76岁,IQR 64-82岁,男163例),ERCP组171例(中位年龄66岁,IQR 57-74岁,男94例);心肺储备低或上消化道明确解剖异常者推荐PTPBD,其余无偏好地提供两种术式;随访包括术后1周、1、3、6个月及之后每6个月腹部CT,复发不能经CT确认时行US和MR cholangiopancreatography;主要结局为技术成功率。
诊断标准与关键数值
- 技术成功率:PTPBD组99%(355/360) vs ERCP组98%(167/171),相对危险度1.02,P=0.12。
- 总体并发症发生率:PTPBD组4%(13/360) vs ERCP组8%(13/171),相对危险度0.27(95%CI:0.12,0.61),P<0.001。
- 透视时间调整后差异:PTPBD较ERCP长28.7分钟(95%CI:22.2,35.2)。
- 辐射剂量调整后差异:PTPBD较ERCP高384.3 mGy(95%CI:296.5,472)。
- 倾向性评分匹配分析(每组n=123)提示PTPBD技术成功率略高且并发症显著更少。
临床应用与阅片要点
- 对心肺储备低或上消化道解剖异常的患者,原文推荐PTPBD作为ERCP的替代术式。
- PTPBD的辐射暴露更高,阅片和报告中应关注透视时间与剂量记录。
- 术后随访采用腹部CT,复发不能经CT确认时补充US和MR cholangiopancreatography。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Endoscopic retrograde cholangiopancreatography (ERCP) is recommended by major guidelines for the removal of common bile duct (CBD) stones but is technically challenging in patients with low cardiopulmonary reserve and anatomic abnormalities of the upper gastrointestinal (GI) tract. Purpose To compare percutaneous transhepatic papillary balloon dilation (PTPBD) with ERCP for CBD stone removal. Materials and Methods Participants with one to three CBD stones (largest stone ≤30 mm) and without intrahepatic bile duct or gallbladder stones were eligible for this prospective cohort study. PTPBD was recommended in participants with low cardiopulmonary reserve or definitive anatomic abnormalities of the upper GI tract. Otherwise, both procedures were offered without preference. Follow-up, including abdominal CT, was conducted at 1-week and 1-, 3- and 6-month follow-up, and every 6 months thereafter. US and MR cholangiopancreatography were conducted if recurrence could not be confirmed with CT. Technical success rate was the primary outcome. Results A total of 531 participants were analyzed: there were 360 undergoing PTPBD (median age, 76 years; interquartile range [IQR], 64-82 years; 163 men) and 171 undergoing ERCP (median age, 66 years; IQR, 57-74 years; 94 men). The technical success rate was 99% (355 of 360) in the PTPBD group and 98% (167 of 171) in the ERCP group (relative risk, 1.02; P = .12). The incidence of overall complications was 4% (13 of 360) for PTPBD and 8% (13 of 171) for ERCP (relative risk, 0.27; 95% CI: 0.12, 0.61; P < .001). The PTPBD group showed a longer fluoroscopy time and a higher radiation exposure, with adjusted differences of 28.7 minutes (95% CI: 22.2, 35.2) and 384.3 mGy (95% CI: 296.5, 472), respectively. A propensity score-matching analysis (n = 123 per group) indicated that PTPBD had a slightly higher technical success rate and significantly fewer complications. Conclusion When compared with endoscopic retrograde cholangiopancreatography, percutaneous transhepatic papillary balloon dilation has a similar technical success rate and fewer perioperative complications but a higher radiation exposure. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by van Sonnenberg and Mueller in this issue.
引用
- Liu B, Ma J, Li S, et al. Percutaneous Transhepatic Papillary Balloon Dilation versus Endoscopic Retrograde Cholangiopancreatography for Common Bile Duct Stones: A Multicenter Prospective Study. Radiology. 2021. PMID: 34060938. doi:10.1148/radiol.2021201115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。